Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Charlotte Beau-Larvor"'
Autor:
Nathalie Corvaia, Eric Chetaille, Mariya Pavlyuk, Cyrille Dreyfus, Michel Perez, Alain Beck, Jean-Francois Haeuw, Thierry Champion, Nicolas Boute, Martine Malissard, Charlotte Beau-Larvor, Alain Robert, Noureddine Loukili, Matthieu Broussas, Barbara Akla
Table S1 shows expression of IGF1R on human tissues Table S2 shows expression of IGF1R on Tumor and Normal cells Table S3 shows DAR calculation Table S4 shows impact of W0101 on cell cycle Figure S1 shows the flowchart for selection of m208F2 Figure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7311e3db6a545594f7793dd543bb27d1
https://doi.org/10.1158/1535-7163.22510686.v1
https://doi.org/10.1158/1535-7163.22510686.v1
Autor:
Nathalie Corvaia, Eric Chetaille, Mariya Pavlyuk, Cyrille Dreyfus, Michel Perez, Alain Beck, Jean-Francois Haeuw, Thierry Champion, Nicolas Boute, Martine Malissard, Charlotte Beau-Larvor, Alain Robert, Noureddine Loukili, Matthieu Broussas, Barbara Akla
The insulin-like growth factor type 1 receptor (IGF-1R) is important in tumorigenesis, and its overexpression occurs in numerous tumor tissues. To date, therapeutic approaches based on mAbs and tyrosine kinase inhibitors targeting IGF-1R have only sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292c0429a3c1405ce33451f4b7f505b2
https://doi.org/10.1158/1535-7163.c.6539682.v1
https://doi.org/10.1158/1535-7163.c.6539682.v1
Autor:
Nicolas Boute, Mariya Pavlyuk, Matthieu Broussas, Barbara Akla, Cyrille Dreyfus, Michel Perez, Charlotte Beau-Larvor, Thierry Champion, Alain Robert, Eric Chetaille, Alain Beck, Noureddine Loukili, Martine Malissard, Jean-François Haeuw, Nathalie Corvaia
Publikováno v:
Molecular cancer therapeutics. 19(1)
The insulin-like growth factor type 1 receptor (IGF-1R) is important in tumorigenesis, and its overexpression occurs in numerous tumor tissues. To date, therapeutic approaches based on mAbs and tyrosine kinase inhibitors targeting IGF-1R have only sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc6f3c2fb7dc2acfcd49d88e3c04fd0
https://pubmed.ncbi.nlm.nih.gov/31594825
https://pubmed.ncbi.nlm.nih.gov/31594825
Autor:
Melissa Excoffier, Christine Klinguer-Hamour, Marie-Claire Janin-Bussat, Lysiane Troncy, Nathalie Corvaia, Charlotte Beau-Larvor, Alain Beck
Publikováno v:
Journal of Chromatography B. 1032:149-154
Antibody-drug conjugates (ADCs) are becoming a major class of oncology therapeutics. They combine monoclonal antibody specificity for over-expressed tumor antigens and the high cytoxicity of small molecular drugs (SMDs) and can therefore selectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7b8700c1b07ccefa3b0cde091c2772c
https://doi.org/10.1016/j.jchromb.2016.05.037
https://doi.org/10.1016/j.jchromb.2016.05.037
Autor:
Liliane Goetsch, Alain Beck, Christian Bailly, Matthieu Broussas, Alexandra Gonzalez, Jean-François Haeuw, Alain Robert, Charlotte Beau-Larvor, Nicolas Boute, Nathalie Corvaia, Thierry Champion
Publikováno v:
International Journal of Cancer. 139:1851-1863
c-Met is a prototypic member of a sub-family of RTKs. Inappropriate c-Met activation plays a crucial role in tumor formation, proliferation and metastasis. Using a key c-Met dimerization assay, a set of 12 murine whole IgG1 monoclonal antibodies was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65322a6db3b2f48bc58243d0e42f7c7f
https://doi.org/10.1002/ijc.30174
https://doi.org/10.1002/ijc.30174
Autor:
Alain Beck, Charlotte Beau-Larvor, Alain Batton, Laurence Zanna, Frédéric Marion, Sarah Cianférani, Philippe Maillos, Jean-François Haeuw, Marion Millet, Thierry Clerc, Barbara Akla, Martine Farrie, Marie-Claire Janin, Nathalie Corvaia, Cyrille Dreyfus, Celine Thuilliez
Publikováno v:
Cancer Research. 80:4054-4054
There are currently 5 antibody drug conjugates (ADC) on the market and over 80 other ADCs evaluated in the clinic. The major drawbacks of the commonly employed bioconjugation methods based on nucleophilic coupling to lysine and cysteine are the non-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84227d4c67908831d0a23c267340584c
https://doi.org/10.1158/1538-7445.am2020-4054
https://doi.org/10.1158/1538-7445.am2020-4054
Autor:
Alain Beck, Charlotte Beau-Larvor, Christine Klinguer-Hamour, Liliane Goetsch, Sven Berger, Matthieu Broussas, Thomas Matthes, Thierry Champion, Alain Robert, Nathalie Corvaia, Nicolas Boute, Barbara Akla, Christian Bailly, Jean-François Haeuw, Charles Dumontet
Publikováno v:
Molecular Cancer Therapeutics, Vol. 15, No 8 (2016) pp. 1890-1899
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, 2016, 15, pp.1890-1899. ⟨10.1158/1535-7163.MCT-16-0041⟩
Molecular Cancer Therapeutics, American Association for Cancer Research, 2016, 15, pp.1890-1899. ⟨10.1158/1535-7163.MCT-16-0041⟩
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, 2016, 15, pp.1890-1899. ⟨10.1158/1535-7163.MCT-16-0041⟩
Molecular Cancer Therapeutics, American Association for Cancer Research, 2016, 15, pp.1890-1899. ⟨10.1158/1535-7163.MCT-16-0041⟩
The type IV C-X-C-motif chemokine receptor (CXCR4) is expressed in a large variety of human cancers, including hematologic malignancies, and this receptor and its ligand, stromal cell–derived factor-1 (SDF-1), play a crucial role in cancer progress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d3899e858a708815717c620ef377724
https://archive-ouverte.unige.ch/unige:88986
https://archive-ouverte.unige.ch/unige:88986
Autor:
Alain Robert, Eric Chetaille, Noureddine Loukili, Charlotte Beau-Larvor, Michel Perez, Jean-François Haeuw, Martine Malissard, Barbara Akla, Alain Beck, Mariya Pavlyuk, Nathalie Corvaia, Cyrille Dreyfus
Publikováno v:
Cancer Research. 78:815-815
Insulin-like growth factor type 1 receptor (IGF-1R) has been recognized for decades for its role in tumorigenesis and growth1. In addition, overexpression of this receptor has been largely documented in numerous tumor tissues. However, so far, previo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff4273301943c90dd305da9a102b591e
https://doi.org/10.1158/1538-7445.am2018-815
https://doi.org/10.1158/1538-7445.am2018-815
Autor:
Alexandra, Gonzalez, Matthieu, Broussas, Charlotte, Beau-Larvor, Jean-François, Haeuw, Nicolas, Boute, Alain, Robert, Thierry, Champion, Alain, Beck, Christian, Bailly, Nathalie, Corvaïa, Liliane, Goetsch
Publikováno v:
International journal of cancer. 139(8)
c-Met is a prototypic member of a sub-family of RTKs. Inappropriate c-Met activation plays a crucial role in tumor formation, proliferation and metastasis. Using a key c-Met dimerization assay, a set of 12 murine whole IgG1 monoclonal antibodies was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d50bf486e06f8bc563e3636932fcfd0
https://pubmed.ncbi.nlm.nih.gov/27144973
https://pubmed.ncbi.nlm.nih.gov/27144973
Autor:
Lysiane Troncy, Bernadette Maynadier, Guillaume Picard, Christine Lacheny, Alain Beck, Michel Jaquinod, Dorothée Lebert, Virginie Brun, Christine Klinguer-Hamour, Walter Low, Nicolas Mouz, Charlotte Beau-Larvor
Publikováno v:
Bioanalysis
Bioanalysis, Future Science, 2015, 7 (10), pp.1237-1251. ⟨10.4155/bio.15.56⟩
Bioanalysis, 2015, 7 (10), pp.1237-1251. ⟨10.4155/bio.15.56⟩
Bioanalysis, Future Science, 2015, 7 (10), pp.1237-1251. ⟨10.4155/bio.15.56⟩
Bioanalysis, 2015, 7 (10), pp.1237-1251. ⟨10.4155/bio.15.56⟩
Background: In preclinical studies, monoclonal antibodies (mAbs) are traditionally assayed by ligand-binding-assays. Recently, quantitative liquid chromatography mass spectrometry (MS)-based assays have emerged which circumvent a number of challenges
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5531ecf6388f66098f9079cb40d7a990
https://hal.archives-ouvertes.fr/hal-02086282
https://hal.archives-ouvertes.fr/hal-02086282